Categories
2023 ASCO

Lung Cancer ASCO 2023 Highlights with Dr. Charu Aggarwal

Discussing Lung Cancer ASCO 2023 Highlights, focusing on practice changing studies with Dr. Charu Aggarwal, Director, Precision Oncology Innovation, Associate Professor of Lung Cancer Excellence at Penn Medicine. Covering three important studies:

– ADAURA trial update with increase OS with adjuvant Osimertinib

– KEYNOTE 789 – Pemetrexed and platinum with or without pembrolizumab for tyrosine kinase inhibitor (TKI)-resistant, EGFR-mutant

– KEYNOTE 671 – Randomized, double-blind, phase 3 study of pembrolizumab or placebo plus platinum-based chemotherapy followed by resection and pembrolizumab or placebo for early stage NSCLC

Categories
2023 ASCO

Breast Cancer ASCO 2023 Highlights with Dr. Stephanie Graff

Discussing Breast Cancer ASCO 2023 Highlights, focusing on practice-changing studies with Dr. Stephanie Graff, Director of Breast Oncology, Associate Professor of Medicine, Lifespan Cancer Institute, Brown University. Covering three important studies:

– NATALEE Phase III study of ribociclib (RIBO) + endocrine therapy (ET) in HR+ patients

– SONIA challenging the need for first-line use of a CDK4/6 Inhibitor in HR+ advanced breast cancer patients

– X-7/7 trial evaluating fixed-dose capecitabine compared to standard dose capecitabine in metastatic breast cancer

Categories
Algorithms Gastrointestinal Cancer Journal

Colon Cancer Algorithm Discussion with Dr. Cathy Eng

Discussing the management of Colon Cancer using the algorithm with Dr. Cathy Eng, MD, Professor of Medicine at the Vanderbilt-Ingram Cancer Center, David H. Johnson Endowed Chair in Surgical & Medical Oncology, Co-Leader Gastrointestinal Cancer Research Program, Co-Director of GI Oncology Program.

Categories
2023 AACR

American Association for Cancer Research (AACR) 2023 Highlights from Community Oncology

Discussing AACR 2023 Highlights – focusing on 3 studies that potentially could impact our practice in the community from this conference.

– AEGEAN study for Non-Small Cell Lung Cancer

– Keynote 966 for Cholangiocarcinoma

– SWOG S1512 for Desmoplastic Melanoma

Categories
Algorithms Journal of Breast Cancer

HR+ Breast Cancer Management with Dr. Margaret Gatti-Mays

Discussing the management of Hormone Receptor Positive Breast Cancer with Dr. Margaret Gatti-Mays, Section Chief of the Breast Medical Oncology at the Ohio State University Comprehensive Cancer Center, The James Cancer Hospital & Solove Research Institute. In our discussion with Dr. Gatti-Mays we cover the treatment algorithm of the hormone receptor-positive disease following the FDA expanding the adjuvant abemaciclib approval where one doesn’t need Ki-67 levels anymore, and new agents recently approved by the FDA – elacestrant, TDXD and sacituzumab providing more treatment options for our patients.

Categories
Algorithms Journal of Breast Cancer

HR+ Invasive Lobular Carcinoma Management with Dr. Jason Mouabbi

Discussing the management of Invasive Lobular Carcinoma with Dr. Jason Mouabbi from the MD Anderson Cancer Center. We see different histologies in hormone receptor-positive breast cancer patients – we will focus on invasive lobular carcinoma in this video. Are these patients different than one with invasive ductal carcinoma? How does the prognosis differs?

Categories
Algorithms Journal of Breast Cancer

HER2+ Breast Cancer Algorithm Discussion with Dr. Paolo Tarantino

Discussing the management using an algorithm of HER 2 Neu Positive Breast Cancer – with Dr. Paolo Tarantino, European Institute of Oncology, Clinical Research Fellow at the Dana-Farber Cancer institute.

Categories
Algorithms Journal of Lung Cancer

Metastatic Non-Small Cell Lung Cancer (NSCLC) Algorithm w/ Targetable Mutations – Dr. Jarushka Naidoo

Discussing the management of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) with targetable mutations using the algorithm – with Dr. Jarushka Naidoo, Professor at Royal College of Surgeons in Ireland, Adjunct Professor at Department of Oncology – Sidney Kimmel Cancer Center at The Johns Hopkins University.

Categories
Algorithms Journal of Lung Cancer

Metastatic Non-Small Cell Lung Cancer (NSCLC) Algorithm w/o Targetable Mutations – Dr. Eric Singhi

Discussing the management of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) without targetable mutations using the algorithm – with Dr. Eric Singhi, Assistant Professor – University of Texas, MD Anderson Cancer Center.

Categories
Algorithms Journal of Lung Cancer

Localized Non-Small Cell Lung Cancer (NSCLC) Algorithm Discussion with Dr. Charu Aggarwal

Discussing the management of Localized Non-Small Cell Lung Cancer (NSCLC) using the algorithm – with Dr. Charu Aggarwal, Associate Director – Penn Center for Precision Medicine, Associate Professor for Lung Cancer Excellence.

Subscribe Now

Document

Dr. Rahul

Dr. Rahul is a Chief of Medical Oncology, making up one-half of the ‘Oncology Brothers.’ He is a valued member of the Guthrie Corning Cancer Center, contributing his extensive knowledge of technology